PHARMA 2100 ApS: Financial statements 2017
CVR: 26382785
PHARMA 2100 ApS (CVR 26382785) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 0 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity amounted to DKK 29,371. The solvency ratio was 100%.
- Revenue
- 0 kr.
- Gross Profit
- -20,455 kr.
- Profit/Loss
- -20,455 kr.
- Equity
- 29,371 kr.
- Total Assets
- 29,371 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 0 | -20 t. | -20 t. | 29 t. | - |
| 2016 | 0 | 0 | 0 | 50 t. | - |
| 2015 | - | -2 t. | -2 t. | 50 t. | - |
| 2014 | 0 | -5 t. | -5 t. | 52 t. | - |
| 2013 | 0 | -250 | -25 t. | 57 t. | - |
Find more companies like PHARMA 2100 ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of December 7, 2017, Niels Meidahl has stepped down as director of PHARMA 2100 ApS.
PHARMA 2100 ApS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 0.
As of April 12, 2017, Niels Meidahl is registered as director of PHARMA 2100 ApS.
As of January 16, 2017, Sven Lange has left the board of directors of PHARMA 2100 ApS.
As of January 16, 2017, Sven Lange has stepped down as adm. dir of PHARMA 2100 ApS.
As of January 16, 2017, Bella da Silva Buxbom has stepped down as chairman of PHARMA 2100 ApS.
About PHARMA 2100 ApS
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002 and dissolved in 2018. The company was registered under the industry Industriel design og produktdesign. The company has 1 employee. In 2017, the company reported revenue of DKK 0 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity amounted to DKK 29,371.
